Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
K&K Biotech is a New Mexico-based biotechnology company specializing in the development of advanced skincare and therapeutic solutions using its proprietary resveratrol analog platform, BioVer-X™. Founded by a biomedical scientist and a botanical skincare artisan, the company leverages the potent anti-inflammatory and antioxidant properties of its patented molecules to address both cosmetic and medical skin conditions. Its lead technology, BioVer-X™, has demonstrated significantly higher bioavailability and efficacy compared to traditional resveratrol in clinical trials for wrinkles and stretch marks. Beyond consumer skincare, K&K Biotech is actively researching medical applications for its technology, including the mitigation of side effects from radiation therapy. The company operates primarily through its consumer-facing brand, K&K Skin Products, while continuing to advance its clinical research pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on K&K.